CIDRAP newsletters options
About 14% of cases worldwide involve healthcare worker, and the rate is as high in 35% in some countries.
A higher quality rating was tied to fewer outbreaks.
High SARS-CoV-2 viral load at hospital admission may place patients with and without cancer at higher risk for death, a new multicenter observational study published in Cancer Cell suggests.
The results of a randomized, controlled clinical trial show that intravesical bacteriophage treatment was non-inferior to standard-of-care antibiotic treatment and safe for treating urinary tract infection (UTI) patients, but it was not superior to placebo in terms of efficacy or safety, researchers reported yesterday in the Lancet Infectious Diseases.
HHS and the Defense Department release 2 documents that outline steps to deliver vaccine.
Tweets on surveillance, technical info, treatment, and symptoms were most likely to be shared.
A COVID-influenza one-two punch could stretch the nation's hospitals to capacity.
India reports 93,824 new cases, continuing its trend of reporting more daily cases than any other nation.
A phase 3 trial for a bivalent Clostridioides difficile toxoid vaccine was terminated because of futility, an international team of investigators led by scientists from Sanofi Pasteur reported yesterday in The Lancet Infectious Diseases.
Live SARS-CoV-2, the virus that causes COVID-19, was isolated from air samples collected 2 to 4.8 meters (6.6 to 15.7 feet) away from two coronavirus patients—one recently released and one newly admitted—in a single hospital room, according to a study published yesterday in the International Journal of Infectious Diseases.
A review highlights multisystem inflammatory syndrome, and another report details no infection in kids who were highly exposed.
A new survey of 158 countries reveals that 1 in 4 haven't set a date for school reopening.
Also, the US has seen a 15% increase in pediatric cases in the past 2 weeks.
The Centers for Disease Control and Prevention (CDC) has issued new recommendations for the prevention and control of Staphylococcus aureus in neonatal intensive care unit (NICU) patients.
Preliminary data from a small study published today in Nature Medicine suggests convalescent plasma may have some efficacy in patients with severe COVID-19.
"A shutdown would destroy the lives and dreams of millions Americans," Trump says.
Inadequate monitoring and tracking allowed the virus to spread unchecked, two studies suggest.
Experts call the global response to the COVID-19 pandemic a "collective failure."
The introduction of a rapid diagnostic test (RDT) in conjunction with antimicrobial stewardship (AMS) activities and infectious disease (ID) consultation at an academic tertiary medical center was associated with shortened time to optimal antibiotic therapy in patients with bloodstream infections, University of Maryland researchers reported in Open Forum Infectious Diseases.
A group of experts from Stanford and Harvard universities, as well as the Dana-Farber Cancer Institute, propose a new model for measuring direct, indirect, and excess deaths from COVID-19 in the United States, and they say relying solely on death certificates likely undercounts the true death toll COVID-19 has taken in the United States. Their proposal is published in the Annals of Internal Medicine.
